OWKIN

Chemistry is no longer the biggest challenge in medicine — biology is, and it remains vastly more complex, dynamic, and poorly understood. The key to unlocking it is understanding and reversing biological aging, especially of the immune system, which drives most major diseases. OWKIN K is the first universal biology copilot, built on reinforcement learning and patient data from 80 of the world’s 100 largest hospitals, designed to discover, validate, and deploy rejuvenation-based interventions across pharma, CROs, biotechs, VCs, and LLM platforms. Led by top talent from Google Brain, Novartis, and DeepMind, OWKIN combines deep scientific credibility with a scalable SaaS + equity model tied to real-world clinical and commercial impact. We’re not building a tool — we’re building the operating system for the future of biology and medicine.